Logo image of CWBR

COHBAR INC (CWBR) Stock Fundamental Analysis

NASDAQ:CWBR - Nasdaq - US19249J3077 - Common Stock - Currency: USD

0.761  -0.14 (-15.44%)

After market: 0.7345 -0.03 (-3.48%)

Fundamental Rating

2

Overall CWBR gets a fundamental rating of 2 out of 10. We evaluated CWBR against 571 industry peers in the Biotechnology industry. The financial health of CWBR is average, but there are quite some concerns on its profitability. CWBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CWBR has reported negative net income.
In the past year CWBR has reported a negative cash flow from operations.
In the past 5 years CWBR always reported negative net income.
In the past 5 years CWBR always reported negative operating cash flow.
CWBR Yearly Net Income VS EBIT VS OCF VS FCFCWBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

The Return On Assets of CWBR (-101.44%) is worse than 79.57% of its industry peers.
CWBR has a Return On Equity of -133.58%. This is in the lower half of the industry: CWBR underperforms 64.45% of its industry peers.
Industry RankSector Rank
ROA -101.44%
ROE -133.58%
ROIC N/A
ROA(3y)-68.44%
ROA(5y)-73.98%
ROE(3y)-75.95%
ROE(5y)-95.1%
ROIC(3y)N/A
ROIC(5y)N/A
CWBR Yearly ROA, ROE, ROICCWBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CWBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWBR Yearly Profit, Operating, Gross MarginsCWBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022

More info and screens

6

2. Health

2.1 Basic Checks

CWBR has more shares outstanding than it did 1 year ago.
CWBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CWBR Yearly Shares OutstandingCWBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M 2M 2.5M
CWBR Yearly Total Debt VS Total AssetsCWBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -13.68, we must say that CWBR is in the distress zone and has some risk of bankruptcy.
CWBR's Altman-Z score of -13.68 is on the low side compared to the rest of the industry. CWBR is outperformed by 84.22% of its industry peers.
CWBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.68
ROIC/WACCN/A
WACCN/A
CWBR Yearly LT Debt VS Equity VS FCFCWBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

CWBR has a Current Ratio of 4.16. This indicates that CWBR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CWBR (4.16) is comparable to the rest of the industry.
A Quick Ratio of 4.16 indicates that CWBR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.16, CWBR is in line with its industry, outperforming 43.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.16
Quick Ratio 4.16
CWBR Yearly Current Assets VS Current LiabilitesCWBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

CWBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.02%, which is quite good.
EPS 1Y (TTM)8.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.7%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CWBR Yearly Revenue VS EstimatesCWBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
CWBR Yearly EPS VS EstimatesCWBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CWBR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CWBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWBR Price Earnings VS Forward Price EarningsCWBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWBR Per share dataCWBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CWBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COHBAR INC

NASDAQ:CWBR (11/28/2023, 8:00:00 PM)

After market: 0.7345 -0.03 (-3.48%)

0.761

-0.14 (-15.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)03-07 2024-03-07/amc
Inst Owners6.24%
Inst Owner Change0%
Ins Owners238.68%
Ins Owner Change0%
Market Cap2.21M
Analysts43.33
Price Target18.36 (2312.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)-4.36
EYN/A
EPS(NY)-4
Fwd EYN/A
FCF(TTM)-2.73
FCFYN/A
OCF(TTM)-2.73
OCFYN/A
SpS0
BVpS3.27
TBVpS3.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -101.44%
ROE -133.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-68.44%
ROA(5y)-73.98%
ROE(3y)-75.95%
ROE(5y)-95.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.16
Quick Ratio 4.16
Altman-Z -13.68
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)8.63%
Cap/Depr(5y)130.18%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.51%
EPS Next Y-3.7%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.94%
OCF growth 3YN/A
OCF growth 5YN/A